$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the safety and potential risks of long-term use of giritinib (segatan)
2026-02-01 22:25:32
Check Details
Analysis of the efficacy and role of Osimertinib (Tagrisso) and actual patient feedback
2026-02-01 22:25:32
Check Details
Efficacy and possible side effects of Eltrombopag (Revlan)
2026-02-01 22:25:32
Check Details
Can Roprostim (Wilgen) cure specific types of thrombocytopenia?
2026-02-01 22:25:32
Check Details
The use of Midostaurin in special groups such as the elderly or patients with abnormal liver and kidney function
2026-02-01 22:25:32
Check Details
Can Cabergoline shrink pituitary tumors and observe its efficacy
2026-02-01 22:25:32
Check Details
How long does the course of Momelotinib (Momelotinib) treatment for blood diseases usually last?
2026-02-01 22:25:32
Check Details
Causes and countermeasures for dizziness after taking Biken Pronol Tablets (Bituvi)
2026-02-01 22:25:32
Check Details
The therapeutic effect of decavatinib on psoriasis and patient feedback
2026-02-01 22:25:32
Check Details
What is the safest and most effective way to take a missed dose of Apremilast (Otelor)?
2026-02-01 22:25:32
Check Details
When is the best time to take Valganciclovir before or after meals?
2026-02-01 22:25:32
Check Details
Analysis of instructions for usage, dosage and precautions of voclosporin
2026-02-01 22:25:32
Check Details
1
2
...
2281
2282
2283
2284
2285
2286
2287
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
2
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
3
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
4
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
5
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
6
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
7
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
12
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition